Mark S. Sulkowski
- Hepatology top 2%
- Epidemiology top 10%
- Infectious Diseases
- Emergency Medicine top 10%
- Hematology
- Co-authors
- Nezam H. AfdhalShruti H. MehtaDavid L. ThomasLisa B. MirelMichael TorbensonRichard D. MooreBetty L. GoonLydia Tang
- Topics
- Hepatitis C virus research (7 papers)Liver Disease Diagnosis and Treatment (5 papers)Chronic Lymphocytic Leukemia Research (2 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Mark S. Sulkowski
12 papers receiving 413 citations
Peers
Comparison fields: 5 of 40
- Hepatology 383
- Epidemiology 344
- Infectious Diseases 81
- Emergency Medicine 50
- Hematology 32
Countries citing papers authored by Mark S. Sulkowski
This map shows the geographic impact of Mark S. Sulkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Sulkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Sulkowski more than expected).
Fields of papers citing papers by Mark S. Sulkowski
This network shows the impact of papers produced by Mark S. Sulkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Sulkowski. The network helps show where Mark S. Sulkowski may publish in the future.
Co-authorship network of co-authors of Mark S. Sulkowski
This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Sulkowski. A scholar is included among the top collaborators of Mark S. Sulkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Sulkowski. Mark S. Sulkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 60 | |
| 5 | 2 | |
| 6 | 52 | |
| 7 | 12 | |
| 8 | 26 | |
| 9 | PREDICTORS OF CONSENT TO PHARMACOGENOMICS TESTING IN THE IDEAL STUDY | 0 |
| 10 | Il28B C/c Genotype Is Predictive of >= 1 Log10 Iu/ml Reduction in Plasma Hcv Rna After 4 Weeks of Peginterferon (Pegifn) and Ribavirin (Rbv) Therapy: Implications for the Use of the Lead-In Strategy for Direct-Acting Antiviral-Based Treatment Regimens | 3 |
| 11 | 23 | |
| 12 | 130 | |
| 13 | 116 | |
| 14 | 2 |
About Mark S. Sulkowski
Mark S. Sulkowski is a scholar working on Hepatology, Hematology and Genetics, having authored 14 papers that have together received 432 indexed citations. Recurring topics across this work include Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Hepatology (383 citations), Epidemiology (344 citations) and Emergency Medicine (50 citations). Mark S. Sulkowski has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Nezam H. Afdhal, Shruti H. Mehta, David L. Thomas, Lisa B. Mirel, Michael Torbenson, Richard D. Moore, Betty L. Goon, Lydia Tang, Peter Bowers and Mitchell L. Shiffman. Their work appears in journals such as Gastroenterology, Hepatology and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.